Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medcan is a Canadian private healthcare company that provides proactive health, preventive screening, primary care, and wellness services for individuals, families, employers, and executive populations. Its core offerings include physician-led annual health assessments, ongoing care memberships, mental health and wellbeing services, weight management and nutrition, fitness and rehabilitation, and employer health programs. The company positions itself around evidence-based, integrated care delivered through in-person and virtual channels, with same- or next-day access for many services. Medcan also offers advanced screening add-ons such as GRAIL's Galleri multi-cancer early detection blood test as part of its preventive health model. Rather than operating as a drug developer, Medcan is a commercial healthcare services business focused on early detection, longitudinal care, and health optimization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medcan.